Xiang Hu Selected Research

Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)

10/2022	HDAC3 single-nucleotide polymorphism rs2530223 is associated with increased susceptibility and severity of primary immune thrombocytopenia.
10/2021	SIRT1 single-nucleotide polymorphisms are associated with corticosteroid sensitivity in primary immune thrombocytopenia patients.
1/2021	Eltrombopag inhibits Type I interferon-mediated antiviral signaling by decreasing cellular iron.
1/2021	Low-Dose Decitabine Inhibits Cytotoxic T Lymphocytes-Mediated Platelet Destruction via Modulating PD-1 Methylation in Immune Thrombocytopenia.
1/2021	Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia.
1/2020	Dexamethasone suppresses the Th17/1 cell polarization in the CD4+ T cells from patients with primary immune thrombocytopenia.
1/2020	Immune Checkpoint-Related Gene Polymorphisms Are Associated With Primary Immune Thrombocytopenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiang Hu Research Topics

Disease

73	Neoplasms (Cancer) 04/2022 - 07/2003
24	Stomach Neoplasms (Stomach Cancer) 08/2021 - 09/2009
22	Insulin Resistance 01/2022 - 10/2010
17	Neoplasm Metastasis (Metastasis) 10/2021 - 05/2010
16	Inflammation (Inflammations) 02/2022 - 04/2010
12	Obesity 05/2022 - 02/2012
10	Osteosarcoma (Osteogenic Sarcoma) 04/2022 - 05/2010
10	Carcinogenesis 08/2021 - 01/2006
9	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2015
9	Wounds and Injuries (Trauma) 05/2021 - 10/2009
8	Non-alcoholic Fatty Liver Disease 01/2022 - 02/2012
7	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2022 - 01/2020
6	Fibrosis (Cirrhosis) 01/2021 - 04/2016
6	Body Weight (Weight, Body) 01/2020 - 04/2011
5	Colonic Neoplasms (Colon Cancer) 01/2022 - 05/2013
5	Atherosclerosis 01/2021 - 06/2015
5	Endometrial Neoplasms (Endometrial Cancer) 11/2020 - 07/2017
5	Rectal Neoplasms (Rectal Cancer) 01/2019 - 06/2010
5	Glioma (Gliomas) 01/2019 - 03/2011
4	Lymphatic Metastasis 12/2021 - 03/2007
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021 - 01/2015
4	Colitis 11/2020 - 01/2016
4	Ischemia 03/2020 - 01/2015
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 08/2014
4	Breast Neoplasms (Breast Cancer) 04/2018 - 03/2013
4	Glioblastoma (Glioblastoma Multiforme) 01/2017 - 05/2013
4	Adenoid Cystic Carcinoma (Cylindroma) 01/2012 - 07/2010
3	Hypertension (High Blood Pressure) 01/2022 - 01/2018
3	Carcinoma (Carcinomatosis) 01/2021 - 08/2013
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 08/2013
3	Infections 01/2021 - 01/2013
3	COVID-19 01/2021 - 01/2020
3	Hypoxia (Hypoxemia) 03/2020 - 07/2017
3	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 08/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2019 - 11/2015
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 03/2018
3	Prostatic Neoplasms (Prostate Cancer) 07/2017 - 12/2013
2	Hemorrhage 10/2022 - 01/2020
2	Disease Progression 10/2022 - 11/2012
2	Diabetic Nephropathies (Diabetic Nephropathy) 02/2022 - 05/2021
2	Ulcer 01/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 04/2022 - 05/2010
15	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 10/2010
12	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2010
11	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 04/2010
11	LipidsIBA 01/2022 - 04/2011
10	Biological ProductsIBA 12/2021 - 05/2013
9	Transcription Factors (Transcription Factor)IBA 01/2019 - 02/2009
8	Peptides (Polypeptides)IBA 01/2022 - 10/2012
8	Messenger RNA (mRNA)IBA 01/2022 - 12/2011
8	IntegrinsIBA 11/2020 - 01/2014
7	Caspase 3 (Caspase-3)IBA 07/2022 - 05/2011
7	Insulin (Novolin)FDA Link 01/2022 - 10/2010
7	CytokinesIBA 05/2021 - 01/2013
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2018 - 08/2010
6	Inosine Triphosphate (ITP)IBA 10/2022 - 01/2020
6	Indicators and Reagents (Reagents)IBA 01/2022 - 04/2014
6	InflammasomesIBA 04/2021 - 01/2013
6	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2015
6	CateninsIBA 01/2017 - 02/2013
5	Pharmaceutical PreparationsIBA 01/2022 - 11/2012
5	Interleukin-10 (Interleukin 10)IBA 11/2020 - 10/2012
5	Therapeutic UsesIBA 01/2020 - 01/2012
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 07/2019 - 10/2013
4	Interleukin-6 (Interleukin 6)IBA 07/2022 - 07/2010
4	FHDIBA 01/2022 - 10/2016
4	AlbuminsIBA 01/2022 - 02/2015
4	CurcuminIBA 05/2021 - 01/2011
4	CollagenIBA 08/2020 - 09/2011
4	Fibroblast Growth Factor-23IBA 01/2018 - 11/2015
3	oxidized low density lipoproteinIBA 11/2021 - 07/2019
3	Phosphotransferases (Kinase)IBA 10/2021 - 08/2010
3	InterferonsIBA 01/2021 - 05/2015
3	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 01/2015
3	isoliquiritigenin (GU 17)IBA 11/2020 - 08/2010
3	Triglycerides (Triacylglycerol)IBA 07/2019 - 07/2017
3	Fluorescent Dyes (Fluorescent Probes)IBA 06/2019 - 12/2009
3	AntigensIBA 04/2018 - 06/2010
3	ParaffinIBA 07/2017 - 05/2010
3	Metformin (Glucophage)FDA LinkGeneric 07/2017 - 01/2014
3	ResveratrolIBA 10/2016 - 11/2011
3	you-gui-wanIBA 01/2015 - 11/2013
3	TOR Serine-Threonine KinasesIBA 01/2012 - 08/2010
2	Toll-Like Receptors (Toll-Like Receptor)IBA 02/2022 - 01/2022
2	QuercetinIBA 01/2022 - 07/2010
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 01/2018

Therapy/Procedure

33	Therapeutics 04/2022 - 03/2011
14	Gastrectomy 01/2019 - 03/2007
11	Drug Therapy (Chemotherapy) 01/2021 - 05/2011
9	Transplantation 01/2021 - 10/2008
7	Lymph Node Excision (Lymph Node Dissection) 01/2020 - 03/2007
5	Negative-Pressure Wound Therapy 01/2018 - 10/2013
4	Adjuvant Chemotherapy 01/2022 - 01/2019
4	Immunotherapy 01/2022 - 10/2013
4	Stem Cell Transplantation 01/2015 - 02/2013
3	Precision Medicine 01/2022 - 05/2014
3	Radiotherapy 11/2020 - 11/2017
3	Mesenchymal Stem Cell Transplantation 01/2020 - 08/2010
3	Caloric Restriction 01/2017 - 04/2011
2	Oral Administration 04/2022 - 07/2012